Skip Nav Destination
Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report
Case Rep Oncol (2020) 13 (1): 304–308.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Cynthia Lizzie Lobo
- Amitha Shetty
- Manohar M
- Akhilesh Dubey
- Sally A. El-Zahaby
AAPS PharmSciTech (2023) 24 (5)
- Essam A. Ali
- Muzaffar Iqbal
- Gamal A. Mostafa
- Mohamed R. Alhazani
- Yousif A. Asiri
Applied Sciences (2022) 12 (17): 8625.
- Joseph William Clinton
- Sara Kiparizoska
- Soorya Aggarwal
- Stephanie Woo
- William Davis
- James H. Lewis
Drug Safety (2021) 44 (11): 1125.
- Jessie Jean Hyppolite
- Aldanie Rho
- Nir Hilzenrat
Canadian Liver Journal (2021) 4 (4): 433.
- Rossana Roncato
- Jacopo Angelini
- Arianna Pani
- Erika Cecchin
- Andrea Sartore-Bianchi
- Salvatore Siena
- Elena De Mattia
- Francesco Scaglione
- Giuseppe Toffoli
International Journal of Molecular Sciences (2020) 21 (17): 6350.
- Syeda Samira Afrose
- Md. Junaid
- Yeasmin Akter
- Mousumi Tania
- Meiling Zheng
- Md. Asaduzzaman Khan
Drug Discovery Today (2020) 25 (12): 2294.
Reactions Weekly (2020) 1812 (1): 110.
